M. Bryan Warf

1.5k total citations
14 papers, 1.1k citations indexed

About

M. Bryan Warf is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, M. Bryan Warf has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in M. Bryan Warf's work include RNA Research and Splicing (7 papers), Cutaneous Melanoma Detection and Management (4 papers) and RNA modifications and cancer (3 papers). M. Bryan Warf is often cited by papers focused on RNA Research and Splicing (7 papers), Cutaneous Melanoma Detection and Management (4 papers) and RNA modifications and cancer (3 papers). M. Bryan Warf collaborates with scholars based in United States, Germany and United Kingdom. M. Bryan Warf's co-authors include J. Andrew Berglund, Charles A. Thornton, Masayuki Nakamori, Peter H. von Hippel, W. Evan Johnson, Brenda Bass, Richard Wenstrup, Darl D. Flake, Benjamin B. Roa and Kathryn A. Kolquist and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

M. Bryan Warf

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Bryan Warf United States	11	960	259	242	155	103	14	1.1k
Edith H. Wang United States	17	825 0.9×	109 0.4×	130 0.5×	50 0.3×	55 0.5×	19	980
Hirohiko Yajima Japan	13	857 0.9×	56 0.2×	293 1.2×	144 0.9×	160 1.6×	19	1.0k
Réda Hadj-Slimane France	16	483 0.5×	98 0.4×	211 0.9×	99 0.6×	29 0.3×	19	786
Emma Sandilands United Kingdom	16	758 0.8×	64 0.2×	124 0.5×	104 0.7×	23 0.2×	26	1.1k
Steven M. Blue United States	13	1.6k 1.6×	86 0.3×	35 0.1×	362 2.3×	36 0.3×	17	1.7k
Sharon Biton Israel	12	1.3k 1.3×	81 0.3×	385 1.6×	361 2.3×	14 0.1×	13	1.5k
Ricky R. Hirschhorn United States	13	829 0.9×	291 1.1×	99 0.4×	84 0.5×	12 0.1×	22	1.0k
Mercedes Dosil Spain	18	929 1.0×	75 0.3×	178 0.7×	65 0.4×	12 0.1×	35	1.2k
Janus S. Jakobsen Denmark	18	1.1k 1.2×	78 0.3×	278 1.1×	69 0.4×	22 0.2×	20	1.5k
Hélène Tourrière France	14	1.5k 1.5×	31 0.1×	205 0.8×	166 1.1×	26 0.3×	16	1.6k

Countries citing papers authored by M. Bryan Warf

Since Specialization

Citations

This map shows the geographic impact of M. Bryan Warf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Bryan Warf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Bryan Warf more than expected).

Fields of papers citing papers by M. Bryan Warf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Bryan Warf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Bryan Warf. The network helps show where M. Bryan Warf may publish in the future.

Co-authorship network of co-authors of M. Bryan Warf

This figure shows the co-authorship network connecting the top 25 collaborators of M. Bryan Warf. A scholar is included among the top collaborators of M. Bryan Warf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Bryan Warf. M. Bryan Warf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Ko, Jennifer S., Balwir Matharoo‐Ball, Steven D. Billings, et al.. (2017). Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes. Cancer Epidemiology Biomarkers & Prevention. 26(7). 1107–1113. 50 indexed citations

Warf, M. Bryan, Kristin Krappmann, Krystal Brown, et al.. (2017). Analytical Validation of a 12-Gene Molecular Test for the Prediction of Distant Recurrence in Breast Cancer. Future Science OA. 3(3). FSO221–FSO221. 9 indexed citations

Clarke, Loren E., Darl D. Flake, Klaus J. Busam, et al.. (2016). An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi. Cancer. 123(4). 617–628. 74 indexed citations

Clarke, Loren E., M. Bryan Warf, Darl D. Flake, et al.. (2015). Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma. Journal of Cutaneous Pathology. 42(4). 244–252. 108 indexed citations

Warf, M. Bryan, Darl D. Flake, Alexander Gutin, et al.. (2015). Analytical Validation of a Melanoma Diagnostic Gene Signature Using Formalin-Fixed Paraffin-Embedded Melanocytic Lesions. Biomarkers in Medicine. 9(5). 407–416. 19 indexed citations

Warf, M. Bryan, Elisha Hughes, M. D. Perry, et al.. (2015). Analytical Validation of a Proliferation-Based Molecular Signature Used as a Prognostic Marker in Early Stage Lung Adenocarcinoma. Biomarkers in Medicine. 9(9). 901–910. 7 indexed citations

Clarke, Loren E., M. Bryan Warf, Darl D. Flake, et al.. (2014). Development and validation of a gene expression signature to distinguish malignant melanoma from benign nevi.. Journal of Clinical Oncology. 32(15_suppl). 9021–9021. 4 indexed citations

Warf, M. Bryan, et al.. (2012). Effects of ADARs on small RNA processing pathways in C. elegans. Genome Research. 22(8). 1488–1498. 49 indexed citations

Warf, M. Bryan, W. Evan Johnson, & Brenda Bass. (2011). Improved annotation of C. elegans microRNAs by deep sequencing reveals structures associated with processing by Drosha and Dicer. RNA. 17(4). 563–577. 45 indexed citations

10.

Warf, M. Bryan & J. Andrew Berglund. (2009). Role of RNA structure in regulating pre-mRNA splicing. Trends in Biochemical Sciences. 35(3). 169–178. 234 indexed citations

11.

Warf, M. Bryan, et al.. (2009). The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing. Proceedings of the National Academy of Sciences. 106(23). 9203–9208. 119 indexed citations

12.

Warf, M. Bryan, et al.. (2009). Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proceedings of the National Academy of Sciences. 106(44). 18551–18556. 212 indexed citations

13.

Voelker, Rodger B., et al.. (2008). Identification of motifs that function in the splicing of non-canonical introns. Genome biology. 9(6). R97–R97. 34 indexed citations

14.

Warf, M. Bryan & J. Andrew Berglund. (2007). MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T. RNA. 13(12). 2238–2251. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact